NASDAQ:TRUPTrupanion Stock Price, Forecast & News

Trupanion's stock was trading at $26.04 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, TRUP shares have increased by 186.0% and is now trading at $74.47.
View which stocks have been most impacted by Coronavirus.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Trupanion in the last year. There are currently 4 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Trupanion.

Trupanion is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Trupanion.

Trupanion Inc (NASDAQ:TRUP) issued its quarterly earnings data on Tuesday, August, 4th. The financial services provider reported $0.04 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.01) by $0.05. The financial services provider earned $117.92 million during the quarter, compared to analysts' expectations of $114.63 million. Trupanion had a net margin of 0.38% and a return on equity of 1.21%. The company's quarterly revenue was up 27.9% compared to the same quarter last year. During the same period in the prior year, the business posted ($0.06) earnings per share.
View Trupanion's earnings history.

8 analysts have issued twelve-month target prices for Trupanion's shares. Their forecasts range from $20.00 to $67.00. On average, they expect Trupanion's share price to reach $45.43 in the next year. This suggests that the stock has a possible downside of 39.0%.
View analysts' price targets for Trupanion.

Media coverage about TRUP stock has trended very positive this week, InfoTrie Sentiment reports. The research firm identifies positive and negative press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Trupanion earned a daily sentiment score of 3.2 on InfoTrie's scale. They also assigned headlines about the financial services provider a news buzz of 6.0 out of 10, meaning that recent press coverage is somewhat likely to have an impact on the company's share price in the next few days.
View the latest news about Trupanion.

Trupanion saw a decrease in short interest in the month of July. As of July 31st, there was short interest totaling 7,360,000 shares, a decrease of 8.2% from the July 15th total of 8,020,000 shares. Based on an average trading volume of 370,900 shares, the days-to-cover ratio is presently 19.8 days. Currently, 25.6% of the company's stock are short sold.
View Trupanion's Current Options Chain.

Some companies that are related to Trupanion include UnitedHealth Group (UNH), Anthem (ANTM), Cigna (CI), Humana (HUM), Centene (CNC), Molina Healthcare (MOH) and Advanzeon Solutions (CHCR).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Trupanion investors own include CA (CA), McEwen Mining (MUX), Endologix (ELGX), BlackRock (BLK), Chipotle Mexican Grill (CMG), Micron Technology (MU), Baidu (BIDU), Gilead Sciences (GILD), Starbucks (SBUX) and Splunk (SPLK).

Trupanion trades on the NASDAQ under the ticker symbol "TRUP."

Trupanion's stock is owned by a number of institutional and retail investors. Top institutional investors include Palisade Capital Management LLC NJ (0.89%), Karani Asset Management LLC (0.37%), Thomas Story & Son LLC (0.25%), Frontier Capital Management Co. LLC (0.25%), Swiss National Bank (0.19%) and First Trust Advisors LP (0.16%). Company insiders that own Trupanion stock include Asher Bearman, Dan Levitan, Darryl Rawlings, Gavin Friedman, H Hays Lindsley, Howard E Rubin, Margaret Tooth, Murray B Low, Robin A Ferracone and Tricia Plouf.
View institutional ownership trends for Trupanion.

TRUP stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Thomas Story & Son LLC, First Trust Advisors LP, Karani Asset Management LLC, RMB Capital Management LLC, Banque Cantonale Vaudoise, and Dupont Capital Management Corp. Company insiders that have sold Trupanion company stock in the last year include Asher Bearman, Darryl Rawlings, Gavin Friedman, H Hays Lindsley, Margaret Tooth, Murray B Low, and Tricia Plouf.
View insider buying and selling activity for Trupanion.

TRUP stock was acquired by a variety of institutional investors in the last quarter, including Frontier Capital Management Co. LLC, Palisade Capital Management LLC NJ, Hamilton Lane Advisors LLC, Parallel Advisors LLC, SG Americas Securities LLC, Swiss National Bank, Leap Investments LP, and Sciencast Management LP.
View insider buying and selling activity for Trupanion.

Shares of TRUP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of TRUP stock can currently be purchased for approximately $74.47.

Trupanion has a market capitalization of $2.61 billion and generates $383.94 million in revenue each year. The financial services provider earns $-1,810,000.00 in net income (profit) each year or ($0.05) on an earnings per share basis. Trupanion employs 586 workers across the globe.

The official website for Trupanion is www.trupanion.com.

Trupanion's mailing address is 6100 4TH AVENUE SOUTH SUITE 200, SEATTLE WA, 98108. The financial services provider can be reached via phone at 855-727-9079 or via email at [email protected]